| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1600-0463.2012.02922.X |
| P698 | PubMed publication ID | 23009118 |
| P50 | author | Hans-Christian Slotved | Q39051725 |
| P2093 | author name string | Maja Hinge | |
| Ingolf Mølle | |||
| Helene A S Ingels | |||
| P433 | issue | 11 | |
| P921 | main subject | multiple myeloma | Q467635 |
| stem cell transplantation | Q65592366 | ||
| pneumococcal vaccine | Q14538008 | ||
| P304 | page(s) | 935-940 | |
| P577 | publication date | 2012-05-22 | |
| P1433 | published in | Acta Pathologica et Microbiologica Scandinavica | Q15756643 |
| P1476 | title | Serologic response to a 23-valent pneumococcal vaccine administered prior to autologous stem cell transplantation in patients with multiple myeloma | |
| P478 | volume | 120 |
| Q34592974 | Association between serotype-specific antibody response and serotype characteristics in patients with pneumococcal pneumonia, with special reference to degree of encapsulation and invasive potential |
| Q39287519 | Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management |
| Q35806621 | Clinical and Microbiological Factors Associated with High Nasopharyngeal Pneumococcal Density in Patients with Pneumococcal Pneumonia |
| Q90317058 | Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients |
| Q47587127 | Guidelines for screening and management of late and long-term consequences of myeloma and its treatment |
| Q38219408 | Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma |
| Q46048464 | Immunogenicity and persistence of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) in patients with untreated Smoldering Multiple Myeloma (SMM): A pilot study |
| Q60699508 | Immunoglobulin G treatment of secondary immunodeficiencies in the era of novel therapies |
| Q28079486 | Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety |
| Q38935505 | Invasive pneumococcal disease in patients with haematological malignancies before routine use of conjugate vaccines in Finland |
| Q38168902 | Pneumococcal immunization in immunocompromised hosts: where do we stand? |
| Q36764389 | Poor Correlation between Pneumococcal IgG and IgM Titers and Opsonophagocytic Activity in Vaccinated Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia |
| Q36388960 | Practical review of immunizations in adult patients with cancer |
| Q98568602 | Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network |
| Q92402845 | Response to pneumococcal vaccination in multiple myeloma |
| Q58799450 | Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease |
| Q38269154 | Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice |
| Q91465250 | Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7) |
Search more.